Jump to content

Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | Madrid
  • Quirónsalud
  • Doubts and queries
  • Web map
  • twitter This link will open in a pop-up window.
  • facebook This link will open in a pop-up window.
  • Youtube This link will open in a pop-up window.
  • Linkedin This link will open in a pop-up window.
  • Instagram This link will open in a pop-up window.
  • Researcher Portal Link to external application.
Language selector
Active language English
  • español
  • English
  • The Institute
    • The Institute
    • Objetives
    • Structure
    • Documents
    • Strategy HRS4R
    • Portal de transparencia
  • Areas and Research Groups
  • Scientific Activity
    • Summary of scientific output
    • Most noteworthy publications
    • Funding
    • Collaborative research
    • Training activities
  • Support Units
    • Research Management Area
    • Core facilities
    • Clinical trials
  • Job
    • Calls and Grants
    • Plan de formación
  • Present
    • News
  • Innovation
    • Who are we?
    • Do you have an idea?
    • Portfolio of services
    • Our technological offers
    • Our successful cases
    • Quality and Innovation Committee
    • Documents
    • Clinical Practice Guidelines
  • Location and contact
  • Colabora con la investigación
  • Portal comunicación interna
  • Home
  •   |   Scientific Activity
  •   |   Training activities
  • Tweet
  • Share on Facebook
  • Share on Linkedin
  • Share on WhatsApp

Training activities

Under construction

  • Logo_AMELIEAMELIE – Anchored Muscle cELls for IncontinencE
  • LOGO_EJP_RDDBAGeneCure - Lentiviral-mediated gene therapy for Diamond Blackfan Anemia: Preclinical Safety and Efficacy Studies
  • LOGO_EJP_RDFANEDIT - Gene editing as a novel therapeutic strategy in Fanconi anemia
  • ERA-PerMedKidney attack - Multidimensional stratification for treatment of acute kidney injury
  • EuropeanComissionMATRIX - Novel mitochondria-targeted therapies for cancer treatment-induced cardiotoxicity
  • ERA-PerMedPersTIgAN - Personalized Treatment in IgA Nephrpopathy
  • EuropeanComissionPRECISMEDLYM – Aggressive T cell Lymphomas, integrated clinical and genomic analysis for a precision medicine
  • LOGO_webPROFID – Implementation of personalised risk prediction and prevention of sudden cardiac death after myocardial infarction
  • logo resilienceRESILIENCE – Remote Ischemic Conditioning in Lymphoma Patients Receiving Anthracyclines
  • EuropeanComissionRITA-MI 2 – Rituximab in patients with acute myocardial infarction: a phase 2 placebo-controlled randomised clinical trial
  • LogoSELNET – Sarcoma as a model to improve diagnosis and clinical care of rare tumors through a European and Latin American multidisciplinary network
  • LogoSTRATEGY-CKD - System omics to unravel the gut-kidney axis in Chronic Kidney Disease
  • unCoVer-blue-logounCoVer - Unravelling Data for Rapid Evidence-Based Response to COVID-19
  • logo UshTherUshTher - Innovative Gene Therapy for USHIB Retinitis Pigmentosa
  • banner quironsalud gris
  • AENOR UNE 166002
Hospital Universitario Fundación Jiménez Díaz

Fundación Jiménez Díaz

Avda. Reyes Católicos, 2
28040 Madrid

91 550 48 00
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

Calle Isaac Peral, 42 oficinas. 2ª planta – oficina 1
28015 Madrid

91 550 48 97investigacion@fjd.es
  • Legal notice
  • Protección de datos
  • Cookie policy
  • Accessibility
  • Web Map
  • twitter This link will open in a pop-up window.
  • facebook This link will open in a pop-up window.
  • Youtube This link will open in a pop-up window.
  • Linkedin This link will open in a pop-up window.
  • Instagram This link will open in a pop-up window.
© 2021 Quirónsalud - All rights reserved
Instituto de Investigación Sanitaria acreditado por el Instituto de Salud Carlos III
Logo ISCIII